Ventyx Biosciences, Inc.
VTYXDelisted Mar 4, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851194
Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Ventyx Biosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 55 | 1 | 63 | +9 |
| Shares | 33.2M | 1.52K | 34.6M | +1.40M (+4.2%) |
| Value | $448.4M | $21.0K | $423.5M | −$24.9M (−5.5%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Ventyx Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HighTower Advisors, LLC | 152,581 | $1.87M | 0.00% |
| Tudor Investment Corp Et Al | 35,595 | $435.0K | 0.01% |
| Rhumbline Advisers | 25,437 | $311.0K | 0.00% |
| Goldman Sachs Group Inc | 18,868 | $231.0K | 0.00% |
| Janney Montgomery Scott LLC | 18,934 | $231.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 17,943 | $219.0K | 0.00% |
| MetLife Investment Management | 13,026 | $159.3K | 0.00% |
| Tokio Marine Asset Management Co Ltd | 10,800 | $132.0K | 0.01% |
| Virtus ETF Advisers LLC | 7,970 | $97.0K | 0.04% |
| Metropolitan Life Insurance Co | 1,512 | $18.5K | 0.00% |
| The PNC Financial Services Group, Inc. | 194 | $2.00K | 0.00% |
| Credit Suisse AG | 17 | $0 | 0.00% |
| CWM, LLC | 15 | $0 | 0.00% |
Sold out (4)
Institutions that held Ventyx Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Millennium Management LLC | 87,706 | $1.19M |
| Putnam Investments LLC | 15,942 | $216.0K |
| Point72 Hong Kong Ltd | 1,175 | $16.0K |
| Cubist Systematic Strategies, LLC | 26 | $0 |
Not filed for Q2 2022 yet (1)
Institutions that held Ventyx Biosciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 1,516 | $21.0K |